Literature DB >> 32663939

A prospective longitudinal study searching for predictors of response to group psychoeducation in bipolar disorder.

María Reinares1, Isabella Pacchiarotti1, Brisa Solé1, Aitana García-Estela2, Adriane R Rosa3, Caterina M Bonnín1, Consuelo De Dios4, Immaculada Torres1, Cristina Varo1, Laura Montejo1, Èlia Valls1, Estanislao Mur-Mila2, Diego Hidalgo-Mazzei1, Esther Jiménez1, Carla Torrent1, José Manuel Goikolea1, Anabel Martínez-Arán1, Víctor Pérez-Sola2, Eduard Vieta5, Francesc Colom6.   

Abstract

BACKGROUND: The efficacy of adjunctive group psychoeducation in bipolar disorder has been proven although treatment response differ among individuals. The aim of this study was to characterize responders and non-responders to group psychoeducation in order to identify baseline variables that could predict treatment response.
METHODS: The sample was composed of 103 medicated euthymic patients with bipolar disorder referred to 21 sessions of group psychoeducation (6 months). Sociodemographic and clinical variables, temperament, circadian rhythms, BDNF, cognitive and psychosocial functioning were collected. At the 18-month endpoint, the patients were split in two groups on the basis of having suffered any recurrence. Significant group differences were included in a logistic regression analysis.
RESULTS: Ninety patients out of 103 engaged in group psychoeducation, 47 of whom (52.2%) responded to psychoeducation and 43 (47.8%) did not. Recurrences occurred more often in the follow-up, the most common being depression. Responders and non-responders differed in gender, age at diagnosis, latency of diagnosis, temperament, attention composite score and BDNF. Lower age at diagnosis of bipolar disorder, lower cyclothimic temperament scores and being male -which was associated with bipolar type I and a trend to more previous manic episodes- were significantly related to a better response to psychoeducation in the regression analysis. LIMITATIONS: No control group.
CONCLUSIONS: This study identifies age at diagnosis as a significant modifiable risk factor of treatment response, highlighting the need for early identification of bipolar disorder. Existing programs should be adjusted to the characteristics of specific subpopulations in the framework of a personalized approach.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Bipolar disorder; Group; Predictors; Psychoeducation; Recurrences; Treatment response

Mesh:

Year:  2020        PMID: 32663939     DOI: 10.1016/j.jad.2020.02.047

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  4 in total

1.  Exploring the Effects of Temperament on Gray Matter Volume of Frontal Cortex in Patients with Mood Disorders.

Authors:  Tao Yang; Raymond W Lam; Jia Huang; Yousong Su; Jing Liu; Xiaorui Yang; Lu Yang; Na Zhu; Guoqing Zhao; Ruizhi Mao; Rubai Zhou; Weiping Xia; Hongmei Liu; Zuowei Wang; Jun Chen; Yiru Fang
Journal:  Neuropsychiatr Dis Treat       Date:  2021-01-22       Impact factor: 2.570

2.  Influence of childhood trauma on the treatment outcomes of pharmacological and/or psychological interventions for adolescents and adults with bipolar disorder: protocol for a systematic review and meta-analysis.

Authors:  Anna Wrobel; Samantha E Russell; Olivia M Dean; Sue Cotton; Michael Berk; Alyna Turner
Journal:  BMJ Open       Date:  2021-04-29       Impact factor: 2.692

3.  Relationships of affective temperament ratings to diagnosis and morbidity measures in major affective disorders.

Authors:  Alessandro Miola; Ross J Baldessarini; Marco Pinna; Leonardo Tondo
Journal:  Eur Psychiatry       Date:  2021-11-23       Impact factor: 5.361

4.  Real-world Implementation of a Smartphone-Based Psychoeducation Program for Bipolar Disorder: Observational Ecological Study.

Authors:  Aitana García-Estela; Jordi Cantillo; Natalia Angarita-Osorio; Estanislao Mur-Milà; Gerard Anmella; Víctor Pérez; Eduard Vieta; Diego Hidalgo-Mazzei; Francesc Colom
Journal:  J Med Internet Res       Date:  2022-02-02       Impact factor: 5.428

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.